tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
Advertisement

Immunovant (IMVT) Similar Stocks

Compare
876 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$17.14
$2.63B
-49.63%
11 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$60.53
$3.71B
84.94
45.86%
9 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$35.61
$3.23B
-29.33%
11 Buy
1 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$76.06
$3.73B
84.97%
10 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$43.51
$3.02B
-4.16%
16 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$59.44
$3.84B
29.16%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
17.14
-16.89
-49.63%
PTGX
Protagonist Therapeutics
60.53
19.03
45.86%
CRNX
Crinetics Pharmaceuticals
35.61
-14.78
-29.33%
MIRM
Mirum Pharmaceuticals
76.06
34.94
84.97%
KYMR
Kymera Therapeutics
43.51
-1.89
-4.16%
MLTX
MoonLake Immunotherapeutics
59.44
13.42
29.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis